(Q43250019)

17 November 2017

Haemodynamic effects and plasma concentrations of labetalol during long-term treatment of essential hypertension (English)

1 reference

17 November 2017

1 reference

Lund-Johansen P

1

1 reference

17 November 2017

Bakke OM

series ordinal

2

1 reference

17 November 2017

language of work or name

English

0 references

publication date

1 February 1979

1 reference

British Journal of Clinical Pharmacology

17 November 2017

1 reference

17 November 2017

7

1 reference

17 November 2017

2

1 reference

17 November 2017

169-174

1 reference

Acute haemodynamic effects of labetalol and its subsequent use of an oral hypotensive agent

17 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1429429

Labetalol in resistant hypertension

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1429429

Haemodynamic long-term effects of a new beta-adrenoceptor blocking drug, atenolol (ICI 66082), in essential hypertension

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1429429

Experience with labetalol in hypertension.

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1429429

Haemodynamic effects of long-term oral labetalol

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1429429

Haemodynamic long-term effects of prazosin plus tolamolol in essential hypertension

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1429429

Labetalol in long-term treatment of hypertension

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1429429

Relationship between plasma concentrations and pharmacological effects of labetalol

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1429429

Pharmacological effects of labetalol in man

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1429429

A review of the animal pharmacology of labetalol, a combined alpha- and beta-adrenoceptor-blocking drug

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1429429

Hemodynamic Long-term Effects of Timolol at Rest and during Exercise in Essential Hypertension

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1429429

Haemodynamic long-term effects of atenolol at rest and during exercise in essential hypertension

25 May 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/760749

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Double-blind trial of labetalol

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/760749

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Hemodynamic changes in long-term diuretic therapy of essential hypertension. A comparative study of chlorthalidone, polythiazide and hydrochlorothiazide

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/760749

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1111/J.1365-2125.1979.TB00917.X

1 reference

17 November 2017

1 reference

17 November 2017

PubMed publication ID

760749

1 reference